Clinical Benefits of a Bloodless Medicine & Surgery Program
Bloodless Medicine and Surgery Programs (BMSP) aim to minimize or eliminate the need for blood transfusions through the use of alternative techniques and treatments. There are a number of risks associated with blood transfusions, including both infectious and non-infectious risks.
Some of the non-infectious risks associated with blood transfusions include:
​
Mistransfusion: Human error can occur during the transfusion process, leading to the wrong blood type being administered to the patient
ABO/Rh-incompatibility: If a patient receives blood that is not compatible with their blood type, it can lead to an immune response that can cause serious complications.
Cardiopulmonary toxicity: Blood transfusions can put a strain on the heart and lungs, especially in patients with pre-existing cardiac or pulmonary conditions.
Transfusion-related acute lung injury (TRALI): TRALI is a rare but serious complication that can occur following a blood transfusion and can lead to respiratory failure.
Transfusion-related immunomodulation: Blood transfusions can suppress the patient's immune system, increasing their risk of infection and delaying recovery.
​
Research has shown that patients who avoid blood transfusions can experience faster recovery times, fewer infections, and shorter hospital stays. By implementing a BMSP, hospitals can reduce the risks associated with blood transfusions and provide safer and more effective medical care to their patients.